Preview

What Is Apotex Controversial

Powerful Essays
Open Document
Open Document
3521 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
What Is Apotex Controversial
In the Business of Health Care
(Apotex’s Controversy)

Arpit Patel
213617477
MGMT 1040
Hope Shamoda
Friday, October 18th, 2014

Review the Main Features of the Case Apotex is an international pharmaceuticals company which manufactures its medicines in various countries. However, it has recently been into news for manufacturing 'unsafe ' drugs with serious side effects. These drugs have been identified as "objectionable", or containing "repeated deficiencies" by the FDA in 16 of their 19 inspections of their drugs manufactured in India(Bruser). After conducting these tests, Apotex was warned about its harmful effects(Bruser), however they ignored these warnings as they did not take any action to improve the safety of their drug.(Bruser) Not only, has Apotex failed to report the harmful effects to
…show more content…
Apotex has a definitive stake in this situation, along with high power. Their high interest is a result from the fact that their reputation, market share, and their future are at stake due to this negative controversies. Apotex has high power in the decisions are made by their name as it can remove the drugs off the market. Also, it can voluntarily recall its drugs that contain harmful side effects. Apotex also has high legitimacy as the “harmful” drugs are causing controversies and reducing consumer confidence in their products. With the increased popularity of social media and internet, more consumers can quickly become aware of the current issues which results in high urgency for Apotex, so that their reputation is not tarnished from their recent actions. Although, Apotex has the right to sell its medicine, the potential consequence from selling unsafe drugs such as a law suit or ban, far outweigh the benefits. Therefore, it makes sense for Apotex to comply with the Health regulators if their drugs are proven to be harmful. Regardless, Apotex is still a definitive stakeholder in the

You May Also Find These Documents Helpful

  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Americans must wait up to 19 years after a discovered treatment before they can participate in benefits of a new medication (Philipson & Sun, 2008). The regulatory process drug manufacturers need to endure before releasing potentially life-saving medication is an extremely expensive, time-consuming process. The Center for Drug Evaluation and Research (CDER) is the main department of the Food and Drug Administration (FDA) responsible for the safety of drugs (both prescription and over-the-counter) sold in the United States (Food and Drug Administration, 2011). This department scrutinizes the testing of new drugs and determines if they are safe and effective before distribution. They do not perform in-house testing themselves; they only evaluate the testing done by the manufacturer to make sure the drug claim is accurate and that the benefits of the medication out way the side-effects (Food and Drug Administration, 2011). Whereas the FDA’s regulation and oversight protects dangerous products from circulation, the approval process hinders manufacturers’ ability to release drugs in a timely manner because of the legal and cost liability, thus preventing the availability of treatment to Americans.…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Powerful Essays

    The Medicines Company

    • 868 Words
    • 5 Pages

    The Medicines Company Case Write-Up: Terence Cho, Felipe Duarte, Aleks Loiko, Robert Shaw, and James Wang…

    • 868 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Bristol Myers

    • 479 Words
    • 2 Pages

    The strategy exerted by Sherman of Apotex was considered to be great judgment call on his part as well as the business. I believe he acted ethically in his strategy and negotiated terms that would benefit his business. He performed extensive research and found many distributors who wanted to purchase Plavix at very low and reasonable cost. On August 8th Apotex launched its generic Drug. Sherman states that, “There should be no mistake that our decision to launch a generic of this blockbuster product at risk is a testament to our commitment to patients, consumers and taxpayers (Baron, 2010). Because he was a good business man he made sure that the product was on the market and sales were soaring.…

    • 479 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Merck’s open letters employ Aristotle’s idea of rhetoric by building appeal with the reader based on three foundations of ethos: wisdom, virtue and goodwill. This strategy is used in attempt to establish credibility and refute The Lancet claim that pharmaceutical giant “acted out of ruthless, shortsighted, and irresponsible self-interest” in Vioxx case. At first, the both documents try to establish Merck’s good judgment and knowledge by insisting the company conforms to ”scientific discipline and transparency”, performs ”rigorous scientific investigation” and brings “new medicines to patients who need them”. In addition, the “Open Letter” argues that as soon as data confirming the increased risks of Vioxx became available, the pharmaceutical giant “acted promptly and made the decision to voluntary withdraw” the drug. The letters further develop ethos with the audience by demonstrating Merck’s history of doing the right thing: “For more than 100 years,” the company “has produced life-saving benefits for countless…

    • 866 Words
    • 4 Pages
    Good Essays
  • Good Essays

    In my point of view, it was unethical for Apotex to include the three-year gag clause in the agreement with Dr.Olivieri. I believe so because according to the article, in the long-term, that drug affected the health of a large number of patients, and probably Apotex was aware of it, which is why they included the gag clause in the contract. Therefore, they should have informed Dr. Oliveiri that that drug could be toxic for the patients.…

    • 388 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Dcpa Pros And Cons

    • 540 Words
    • 3 Pages

    Before the long-term safety of a drug is known, it is often already being presented to the public. Also, FDA clinical trials that are required for product approval characteristically are not constructed to identify rare and adverse effects. Take Vioxx for instance. Vioxx was a heavily promoted drug in the late 1990s and early 2000s. With over $100 million spent in advertising by Merck, the drug raked in over $1 billion annually. Asking for Vioxx, thinking it was a superior medication, patients were not aware that the drug could lead to heart attacks…

    • 540 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    PharmaCare essay

    • 3754 Words
    • 16 Pages

    The twenty-first century has seen pharmaceutical companies grow in unprecedented size and strength. Due to the unprecedented growth the larger pharmaceutical companies have gained leverage and power in the prescription drug industry, but they lack innovation to market and they seek ways to help the business continue to increase its profits. The pharmaceutical industry was once ethically sound and was a valuable player in the development of human health. However, overtime with the lack of innovation pharmaceutical companies are becoming an unethical market that exploits patients, doctors and anyone else it can to increase its profitability. With eyes only on profitability this can create a hazard for patients because there is deficient testing of the drugs prior to the drugs hitting the American market. In this research paper we will cover the many facets of PharmaCare, Coleria, and Wellco and the drug AD23 side effects, and its manufacturing in an impoverished nation with the low wages and unsafe working conditions. All of which will be covered throughout this document.…

    • 3754 Words
    • 16 Pages
    Powerful Essays
  • Better Essays

    Follow the link below, read the article and analyze the practice of “dumping” dangerous drugs overseas. Can an American company be penalized for marketing a product deemed unsafe by the U.S., if it is not also banned by the foreign government?…

    • 1025 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Discovering dangers of prescription drugs after they have been marketed to the medical community and public is common. Generally, 51% of FDA-approved drugs have serious adverse effects not detected prior to approval.1 Each year prescription drugs injure 1.5 million people so severely they require hospitalization. In addition, prescription drugs cause 100,000 deaths annually. With these numbers, how can the public be protected from dangerous…

    • 1186 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Brain Gym Analysis

    • 1243 Words
    • 5 Pages

    Drug companies distribute and promote their changed results in academic journals, tricking very nearly anybody into putting their dangerous and inaccurately tested drugs on the market. In duplicate publication if a drug company gets a better result, they will republish their findings in slightly different ways and in multiple academic sources. “One drug called ondansetron managed to overestimate the drug's effect by 23% using this method” (Goldacre, 2011, pp.164-165). Side effects usually happen and can often be severe. Harmful side effects and their negative results, when known, can discourage medicine buyers. Drug companies can muffle the negative reactions by contrasting them with horrible symptoms that another, comparative medication may have. According to drugwatch.com, one type 2 diabetes drug, Actos, which was prescribed 10 million times and FDA approved, increases the chance of bladder cancer by 40% and causes an increased risk of heart failure. Vioxx a painkiller that was approved in 1999 by the FDA was studied in a trial against an older drug, naproxen, to compare the different side effects much money was invested in the trial, and the pending…

    • 1243 Words
    • 5 Pages
    Good Essays
  • Satisfactory Essays

    The Food and Drug Administration has the power to force businesses that make or sell defective products to take corrective action.…

    • 1126 Words
    • 8 Pages
    Satisfactory Essays
  • Powerful Essays

    Health Care Communications

    • 1397 Words
    • 6 Pages

    As the Communication Coordinator for this well known drug manufacturer, we will now debate and discus how we will get information to the public about the negative effects that our medications are causing the public. Our goal, as a vital asset to the public and medical community, is to convey all concerns to our community in a very sensitive and careful way. Using the power of newspapers, radio, internet, social networking and news related companies. The local news has already reported that a well-known public figure has been effected which goes against the health portability and accountability act. So as communication coordinator it is important to communicate this issue carefully, addressing the proper population, without losing business and the trust we created with our investors and consumers. Today in our meeting, we will discuss very important aspects of our company’s medical concerns and deciding which communication tactic is most suitable for this situation, while sticking to the very important and necessary HIPPAA guidelines.…

    • 1397 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    However, when searching on website of the Chinese regulatory authority of drugs, China Food and Drug Administration, you may find there are many announcements of adverse drug reaction reports for those that drugs made by overseas and multinational pharmaceutical manufacturers. How to report an adverse drug reaction and event to the Chinese regulatory authorities? Who should report adverse drug reaction and event to the Chinese regulatory authorities? How the Chinese regulatory authorities to monitor the adverse drug reaction and event reporting? How to comply with Chinese regulations for adverse drug reaction reporting and monitoring? A series of questions are facing overseas and multinational pharmaceutical manufacturers. The overseas and multinational pharmaceutical manufacturers and their senior executive officers engaging in regulatory affairs need a comprehensive and thorough knowledge of the Chinese regulations for adverse drug reaction…

    • 397 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Some medicines are beyond the scope of the FDA regulatory authority or some are approved to be used in other ways. Often some problems occur after the product has been approved by the FDA (Hooper, 2008). A manufacturer of the popular cholesterol reducing drug recalled 40 batches after finding out that it may contain small particles of glass. The glass particles were similar to the size of a grain of sand. If ingested it could be dangerous. There were no true adverse effects related to the recall are very low which means there are no injuries reported The pharmaceutical company Ranbaxy is recalling bottles of 10, 20, and 40 milligram tablets atorvastatin calcium, the generic version of Lipitor. The FDA granted the company approval of the manufacture of drug in New Jersey in 2011. Ranbaxy has been under the radar since 2006 for submitting false data to FDA and barred the company from manufacturing drugs in the United States until they met standards. Patients needed to find out if they pills they are taking are in the recall. All pharmacies recommend patients to check and see if their medicine is included in the recall before they take another dosage of their medicine. The patients do not have to do much as far as insurance purposes because they are automatically notified. If patient receives their medicine from the pharmacy they can swap out their pills there and mail order patients will…

    • 736 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Cabot

    • 370 Words
    • 2 Pages

    Huellas de la carrera de 12 años de un vendedor de productos farmacéuticos, Bob Marsh, desde la contratación hasta el despido. El Sr. Marsh ha tenido una carrera desigual con Cooper Pharmaceuticals, Inc. (IPC) y, después de un período de prueba, se le pide que renuncie. Después de su terminación, una serie de antiguos clientes de Marsh se quejan enérgicamente, y el presidente del IPC es vicepresidente de ventas se le pide que investigue el asunto y decidir lo que, en todo caso, a hacer al respecto.…

    • 370 Words
    • 2 Pages
    Good Essays